Johnson & Johnson (i)(JNJ) zählt zu den führenden Gesundheitskonzernen weltweit – mit einem starken Portfolio in Pharmazeutik und Medizintechnik. Trotz…
Caverion Press release, 16 July 2025 at 09:00 CET
The companies have committed to strengthening their existing partnership in industrial refrigeration…
Press release
17 July 2025 at 09:00 CET
Caverion Suomi Oy and Johnson Controls Finland Oy have signed an agreement whereby Caverion…
Key PointsExxonMobil has the best dividend growth track record in the oil industry. Johnson & Johnson has increased its dividend…
…
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025.…
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025.…
Johnson & Johnson (NYSE:JNJ) reported Q2 2025 earnings on July 16, 2025, posting sales of $23.7 billion (up 4.6%), with…
Key PointsJohnson & Johnson delivered a "beat and raise" quarter. Results were bolstered by the new acquisition of Intra-Cellular, marking…
Key PointsAdjusted EPS reached $2.77 in Q2, topping estimates by $0.09, but fell year over year.Revenue rose 5.8% year over…
The Dow Jones Industrial Average is up Wednesday afternoon with shares of Johnson & Johnson and Amgen seeing positive momentum…
These are the stocks posting the largest moves in midday trading.…
Image source: The Motley Fool.
DATEWednesday, July 16, 2025 at 8:30 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Joaquin DuatoChief…
…
Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…
Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…
…
The headline numbers for Johnson & Johnson (JNJ) give insight into how the company performed in the quarter ended June…
Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…
NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) blickt nach einem überraschend guten zweiten Quartal zuversichtlicher auf das…
NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) blickt nach einem überraschend guten zweiten…
These are the stocks posting the largest moves in premarket trading.…
Key PointsDividend stocks are one of the most powerful investing tools to build wealth. The S&P 500 has plenty of…
Johnson & Johnson reported second-quarter profit and raised its full-year sales forecast by around $2 billion on Wednesday as strong…
Johnson & Johnson (NYSE:JNJ) shares edged higher premarket as the healthcare firm reported an earnings beat for the second quarter…
Johnson Controls names Chris Scalia as new HR chief…
Key PointsDividend stocks have historically outperformed non-dividend payers. Several companies have excellent records of paying a growing dividend. Theyre worth…
Key PointsKenvue is spending big to drum up demand for its diversified product portfolio.The companys weak results reflect pressure on…
Key PointsJohnson & Johnson reports earnings on Wednesday.Investors may be paying attention to tariff-related developments more so than the companys…
Key PointsThe investment advisor sold 38,037 shares for a total of $6.31 million in Q2 2025.Move removes JNJ from portfolio,…
Key PointsJohnson & Johnson has delivered excellent returns to its long-term shareholders. One key factor behind the companys success is…
Key PointsMotley Fool CEO Tom Gardner is worried that the "market" is a bit stretched valuation-wise.Gardner thinks there are still…
Johnson & Johnson (JNJ) possesses the right combination of the two key ingredients for a likely earnings beat in its…
Key PointsEmerson Electric has restructured its business to focus on long-term growth opportunities.Kenvue is a good choice for investors mainly…
…
Johnson Controls stock hits all-time high at 106.98 USD…
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…
Key PointsJohnson & Johnson is a Dividend King.The stock offers an attractive 3.4% dividend yield.Another healthcare stock has a 7.4%…
Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…
MU gains 42.5% YTD as AI demand fuels DRAM growth, while JNJ and HD navigate pricing, pipeline, and macro headwinds.…
Buying an exchange-traded fund (ETF) that tracks an index like the S&P 500 can be a great way to build…
Johnson & Johnson (JNJ) concluded the recent trading session at $155.92, signifying a +2.08% move from its prior days close.…
Exchange-traded funds (ETFs) make investing easy. While you may be able to make more money by investing in individual stocks,…
Artificial intelligence (AI), big tech, and cryptocurrencies all have their fans among investors, and with good reason. All can add…
Many, if not most, of us would do well to include a bunch of dividend payers in our portfolio. Naturally,…
Investing in exchange-traded funds (ETFs) is a great way for both new and experienced investors to gain market exposure, and…
Johnson & Johnson (NYSE: JNJ) is an iconic U.S. healthcare giant. It has changed over the years, but today its…
RACINE, Wis., June 26, 2025 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of…